Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 15, 2020 - Issue 11
Submit an article Journal homepage
222
Views
4
CrossRef citations to date
0
Altmetric
Review

Explaining biosimilars and how reverse engineering plays a critical role in their development

Salvatore BellinviaDepartment of Rheumatology and NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0697-3191View further author information
ORCID Icon &
Christopher J. EdwardsDepartment of Rheumatology and NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UKView further author information
Pages 1283-1289 | Received 12 May 2020, Accepted 08 Jul 2020, Published online: 27 Jul 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nimer S Alkhatib, Shiraz Halloush & Ivo Abraham. (2023) The status and preparation for the next decade of biosimilars in the Middle Eastern and North African region. Expert Opinion on Biological Therapy 23:8, pages 671-677.
Read now

Articles from other publishers (3)

Lei Zhang, Lu Yu, Yanpeng Xu, Peilan Qin, Pengcheng Shen, Kemeng Liu, Mengdan Fei, Hongya Wang, Yanjing Cao, Lihong Lu, Wenyuan Gao & Zhongli Zhang. (2023) Demonstrating analytical similarity of a biosimilar HLX04 to bevacizumab with a panel of state-of-the-art methods and tiering of quality attributes. Analytical and Bioanalytical Chemistry 415:17, pages 3341-3362.
Crossref
Simran Kaur, Junaid Ul Hamid & Sunil Gupta. (2023) Reverse Engineering of Medicinal and Nutritional Products - Approaches Available for Generic Product Development. Current Analytical Chemistry 19:2, pages 130-146.
Crossref
Çağla KÜÇÜK, Özlem ATEŞ DURU, Esra MUTLU & Hande KAZAK SARİLMİSER. (2021) Biyobenzer İlaçlar. Beykent Üniversitesi Fen ve Mühendislik Bilimleri Dergisi 13:2, pages 34-42.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.